16.10.2023
Publications category: MIDD
10.10.2023
A disease model predicting placebo response and remission status of patients with ulcerative colitis using modified Mayo score
06.10.2023
Use of quantitative systems pharmacology pipelines to bridge in vitro and in vivo results in drug discovery
23.08.2023
Model Informed Drug Development: Collaboration Through A Common Framework
23.08.2023
Model-informed drug development of autologous CAR-T cell therapy: Strategies to optimize CAR-T cell exposure leveraging cell kinetic/dynamic modeling
23.08.2023
Towards Industrialisation of Probability of Pharmacological Success (PoPS)
22.08.2023
Application of tumor size modelling and simulations to support the dose selection of BI 907828 for a Phase II study
22.08.2023
Optimizing infusion rates for N,N-dimethyltryptamine based on either a continuous variable model or a bounded integer model
22.08.2023
Physiologically based pharmacokinetic (PBPK) modeling of the oral absorption of 5-flucytosine to support further development of a sustained-release formulation for the treatment of cryptococcal meningoencephalitis
22.08.2023
Virtual patients, digital twins and causal disease models: Paving the ground for in silico clinical trials
22.08.2023